Dose escalation study of carboplatinpemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer

Author： Tamiya A.   Tamiya M.   Shiroyama T.   Kanazu M.   Hirooka A.   Tsuji T.   Morishita N.   Asami K.   Suzuki H.   Okamoto N.   Okishio K.   Kawaguchi T.   Hirashima T.   Atagi S.   Kawase I.  

Publisher： Oxford University Press

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.4, 2013-04, pp. : 980-985

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with nonsquamous nonsmall cell lung cancer

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2453-2457

Spandidos Publications

Access to resources Recommend Favorite

Maintenance Bevacizumab is Associated With Increased Hemoglobin in Patients With Advanced, Nonsquamous, Non-Small Cell Lung Cancer

By Riess Jonathan W.   Logan Aaron C.   Krupitskaya Yelena   Padda Sukhmani   Clément-Duchêne Christelle   Ganjoo Kristen   Colevas A. Dimitrios   Pedro-Salcedo Melanie San   Kuo Calvin J.   Wakelee Heather A.  

Cancer Investigation, Vol. 30, Iss. 3, 2012-02 ,pp. : 231-235

Informa Healthcare

Access to resources Recommend Favorite

Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer

By                      

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2577-2582

Spandidos Publications

Access to resources Recommend Favorite

Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 646-650

Bentham Science Publishers

Access to resources Recommend Favorite

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer

By Maestu I.   Gomez-Aldaravi L.   Torregrosa M.D.   Camps C.   Llorca C.   Bosch C.   Gomez J.   Giner V.   Oltra A.   Albert A.  

Lung Cancer, Vol. 42, Iss. 3, 2003-12 ,pp. : 345-354

Elsevier

Access to resources Recommend Favorite